Xenogen Biosciences offers a new in vivo comprehensive compound profiling program for preclinical research. Xenogen’s Comprehensive Com-pound Profiling Program is a customized battery of pharmacological tests to (i) assess the therapeutic efficacy of (optimized) lead compounds and/or drug development candidates by analyzing their effects on key physiological functions in animals, (ii) screen for potential side effects caused by the administration of such compounds, and/or (iii) discover disease indications for such compounds that were not previously known, helping expand the market potential of those drug candidates.

 

Xenogen Biosciences

877.936.6436

www.xenogen.com